New Investigator Research Grant Program - Leukemia & Lymphoma Society
Funds early-career scientists for innovative research advancing understanding and treatment of leukemia and myelodysplastic syndromes.
Funder: Leukemia & Lymphoma Society
Due Dates: February 6, 2026 (LOI deadline) | April 13, 2026 (Full application, if invited)
Funding Amounts: Up to $150,000 total over 2 years; no indirect costs; no PI salary support.
Summary: Supports early-career independent investigators for innovative leukemia and MDS research projects to advance scientific understanding and patient outcomes.
Description
This program funds independent, early-career researchers to conduct impactful, innovative research focused on leukemia, with proposals on myelodysplastic syndromes (MDS) also accepted. The aim is to foster new directions in leukemia research and support investigators within seven years of their first independent faculty-level appointment. The grant is designed to help launch the careers of promising scientists and advance research that can improve outcomes for leukemia patients. Researchers from diverse backgrounds and institutions, including those outside the US, are encouraged to apply.
